SCHEMBL233464

SCHEMBL233464

O=C(O)c1ccccc1Sc1cccc(OC(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 2/20 0.57
DHODH Q02127 2/20 0.46
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
POLB P06746 1/20 0.42
IGF2BP2 Q9Y6M1 1/20 0.42
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
NOTUM Q6P988 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KCNK2 O95069 1/20 0.40
KCNK10 P57789 1/20 0.40
MGLL Q99685 2/20 0.40
KAT6A Q92794 1/20 0.40
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5030912 0.82 EDNRA (0.55) SIRT1POLBKDM4E
SCHEMBL8533504 0.79 MAPT (0.56) DHODHLMNAMAPTHTTSIRT1
SCHEMBL685431 0.78 MGLL (0.53) RHEBNOTUMKDM4EALDH1A1KCNK2
SCHEMBL22400326 0.77 NOTUM (0.50) RHEBNOTUMMGLL
SCHEMBL30688795 0.77 NOTUM (0.50) RHEBNOTUMMGLL
SCHEMBL26676266 0.77 SIRT1 (0.51) LMNAMAPTHTTSIRT1POLB
SCHEMBL8639079 0.76 POLB (0.57) LMNAMAPTHTTSIRT1POLB
SCHEMBL231042 0.75 SIRT1 (0.71) LMNAMAPTHTTSIRT1POLB
SCHEMBL1447741 0.75 KDM4E (0.59) MAPTSIRT1POLBKDM4EALDH1A1
SCHEMBL6934354 0.75 SIRT1 (0.53) LMNAMAPTHTTSIRT1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R RHEB 3811/4885DHODH 82/4885LMNA 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.